Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease.

Wangberg, Hannah; Spierling Bagsic, Samantha R; Osuna, Lilliana; White, Andrew A

Wangberg, Hannah; Spierling Bagsic, Samantha R; Osuna, Lilliana; White, Andrew A.

Wangberg H; Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, Calif.
Spierling Bagsic SR; Scripps Health, Scripps Whittier Diabetes Institute, San Diego, Calif.
Osuna L; Scripps Health, Scripps Whittier Diabetes Institute, San Diego, Calif.
White AA; Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, Calif. Electronic address: White.Andrew@scrippshealth.org.

J Allergy Clin Immunol Pract ; 10(2): 478-484.e3, 2022 02.

Article en En | MEDLINE | ID: mdl-34597850

Asunto(s)

Asma Inducida por Aspirina; Pólipos Nasales; Rinitis; Aspirina/uso terapéutico; Asma Inducida por Aspirina/terapia; Terapia Biológica; Enfermedad Crónica; Humanos; Pólipos Nasales/tratamiento farmacológico; Proyectos Piloto; Estudios Prospectivos; Estudios Retrospectivos; Rinitis/terapia

Palabras clave

Aspirin-exacerbated respiratory disease (AERD); Asthma; Benralizumab; Biologic; Chronic rhinosinusitis with nasal polyposis (CRSwNP); Dupilumab; Mepolizumab; NSAID-exacerbated respiratory disease (NERD); Nasal polyps; Omalizumab; Reslizumab

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rinitis / Pólipos Nasales / Asma Inducida por Aspirina Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google